Company news from the 01/09/07 news brief
Boehringer Ingelheim and Ablynx have jointly announced an exclusive worldwide collaboration and license agreement worth approximately $265 million to discover ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.